Zhejiang Jolly Pharmaceutical Co., Ltd. engages in the research, production, and marketing of Chinese medicinal products in China and internationally. The company offers Wuling capsule that is used to treat insomnia, amnesia, heart palpitations, lack of energy, lassitude in loin and legs, and giddy tinnitus, as well as deficiency of energy and weak pulse caused by the disharmony of heart and kidney, or neurasthenia. It also provides Lingze tablet, which is used to treat frequent urination, dysuria, weak steam of urine, endless urine, and soreness and weakness of waist and knees caused by benign prostatic hyperplasia, kidney deficiency, and blood stasis; and Bailing tablet that is used as the adjuvant therapy to treat cough, asthma, back pain, and chronic bronchitis, which are caused by the deficiency of lungs and kidney. In addition, the company offers Linglianhua particles for the treatment of symptoms, including sweating, insomnia, dysphoria, heart palpitations, dreaminess, giddy tinnitus, lassitude in loin and legs, dry stool, and abnormal furred tongue, as well as weak pulse caused by perimenopausal syndrome, or disharmony of heart and kidney. Further, it provides azithromycin, clindamycin phosphate, doxapram, pefloxacin mesylate, adenosine cyclophosphate, and sodium nitroprusside injections. Additionally, the company offers materials, such as cordyceps cephalosporium, fermented cordyceps, and Wuling powders. It also invests and participates in the medical services of Deqing No.3 People's Hospital. The company was formerly known as Zhejiang Jolly Pharmaceutical Health Products Co., LTD. and changed its name to Zhejiang Jolly Pharmaceutical Co., Ltd. in 1998. Zhejiang Jolly Pharmaceutical Co., Ltd. was founded in 2000 and is based in Huzhou, China.
Zhejiang Jolly Pharmaceutical Dividend Announcement
• Zhejiang Jolly Pharmaceutical announced a annually dividend of ¥0.45 per ordinary share which will be made payable on 2024-05-22. Ex dividend date: 2024-05-22
• Zhejiang Jolly Pharmaceutical annual dividend for 2024 was ¥0.45
• Zhejiang Jolly Pharmaceutical annual dividend for 2023 was ¥0.30
• Zhejiang Jolly Pharmaceutical's trailing twelve-month (TTM) dividend yield is 2.73%
• Zhejiang Jolly Pharmaceutical's payout ratio for the trailing twelve months (TTM) is 100.18%
• Zhejiang Jolly Pharmaceutical's dividend growth over the last five years (2018-2023) was 71.88% year
• Zhejiang Jolly Pharmaceutical's dividend growth over the last ten years (2013-2023) was 11.61% year
Zhejiang Jolly Pharmaceutical Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-05-22 | ¥0.45 | annually | 2024-05-22 |
2023-05-30 | ¥0.30 | annually | 2023-05-30 |
2022-05-31 | ¥0.20 | annually | 2022-05-31 |
2021-05-31 | ¥0.10 | annually | 2021-05-31 |
2020-06-04 | ¥0.02 | annually | 2020-06-04 |
2019-05-16 | ¥0.08 | annually | 2019-05-16 |
2018-05-30 | ¥0.02 | annually | 2018-05-30 |
2017-05-11 | ¥0.02 | annually | 2017-05-11 |
2016-06-16 | ¥0.07 | annually | |
2015-05-20 | ¥0.34 | annually | |
2014-03-04 | ¥0.50 | annually | |
2013-06-13 | ¥0.10 | annually |
Zhejiang Jolly Pharmaceutical Dividend per year
Zhejiang Jolly Pharmaceutical Dividend growth
Zhejiang Jolly Pharmaceutical Dividend Yield
Zhejiang Jolly Pharmaceutical current trailing twelve-month (TTM) dividend yield is 2.73%. Interested in purchasing Zhejiang Jolly Pharmaceutical stock? Use our calculator to estimate your expected dividend yield:
Zhejiang Jolly Pharmaceutical Financial Ratios
Zhejiang Jolly Pharmaceutical Dividend FAQ
Other factors to consider when evaluating Zhejiang Jolly Pharmaceutical as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Zhejiang Jolly Pharmaceutical stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Zhejiang Jolly Pharmaceutical's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Zhejiang Jolly Pharmaceutical publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Zhejiang Jolly Pharmaceutical distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Zhejiang Jolly Pharmaceutical are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Zhejiang Jolly Pharmaceutical sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Zhejiang Jolly Pharmaceutical distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Zhejiang Jolly Pharmaceutical declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Zhejiang Jolly Pharmaceutical's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Zhejiang Jolly Pharmaceutical's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.